Pharmaceutical Security Production Act

Bill 118 HR 4449, also known as the Pharmaceutical Security Production Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to enhance the security and safety of pharmaceutical products in the United States.

The bill requires pharmaceutical manufacturers to implement security measures in their production processes to prevent counterfeit drugs from entering the market. This includes implementing track-and-trace systems to monitor the movement of pharmaceutical products from production to distribution.

Additionally, the bill mandates that pharmaceutical manufacturers must verify the authenticity of their products through the use of unique identifiers, such as serial numbers or barcodes. This will help to ensure that consumers are receiving genuine and safe medications. Furthermore, the bill establishes penalties for those who engage in the counterfeiting or tampering of pharmaceutical products. This includes fines and potential imprisonment for individuals found guilty of these crimes. Overall, the Pharmaceutical Security Production Act aims to protect consumers from counterfeit drugs and ensure the safety and integrity of the pharmaceutical supply chain in the United States.